A detailed history of Alternative Investment Advisors, Llc. transactions in Geron Corp stock. As of the latest transaction made, Alternative Investment Advisors, Llc. holds 19,597 shares of GERN stock, worth $80,347. This represents 0.05% of its overall portfolio holdings.

Number of Shares
19,597
Holding current value
$80,347
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 26, 2024

BUY
$3.1 - $5.09 $60,750 - $99,748
19,597 New
19,597 $83.1 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.55B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Alternative Investment Advisors, Llc. Portfolio

Follow Alternative Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alternative Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Alternative Investment Advisors, Llc. with notifications on news.